Grindeks (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Grindeks" in Catalan language version.

Last modified:

Ref.Un. Ref.Website
Global rank Catalan rank
1st place
1st place
low place
low place
2nd place
4th place
5th place
7th place
low place
low place
low place
low place
low place
low place
28th place
10th place

archive.today (Global: 28th place; Catalan: 10th place)

biotech-intelligence.com (Global: low place; Catalan: low place)

ceepharma.com (Global: low place; Catalan: low place)

doi.org (Global: 2nd place; Catalan: 4th place)

dx.doi.org

  • Sesti C, Simkhovich BZ, Kalvinsh I, Kloner RA «Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics». J. Cardiovasc. Pharmacol., 47, 3, 3-2006, p. 493–9. DOI: 10.1097/01.fjc.0000211732.76668.d2. PMID: 16633095.
  • Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M «Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction». J. Cardiovasc. Pharmacol., 48, 6, 12-2006, p. 314–9. DOI: 10.1097/01.fjc.0000250077.07702.23. PMID: 17204911.
  • Hayashi Y, Kirimoto T, Asaka N, Nakano M, Tajima K, Miyake H, Matsuura N «Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction». Eur. J. Pharmacol., 395, 3, 5-2000, p. 217–24. DOI: 10.1016/S0014-2999(00)00098-4. PMID: 10812052.
  • Leung IK, Krojer TJ, Kochan GT, Henry L, von Delft F, Claridge TD, Oppermann U, McDonough MA, Schofield CJ «Structural and mechanistic studies on γ-butyrobetaine hydroxylase». Chem. Biol., 17, 12, 12-2010, p. 1316–24. DOI: 10.1016/j.chembiol.2010.09.016. PMID: 21168767.
  • Tars K, Rumnieks J, Zeltins A, Kazaks A, Kotelovica S, Leonciks A, Sharipo J, Viksna A, Kuka J, Liepinsh E, Dambrova M «Crystal structure of human gamma-butyrobetaine hydroxylase». Biochem. Biophys. Res. Commun., 398, 4, 8-2010, p. 634–9. DOI: 10.1016/j.bbrc.2010.06.121. PMID: 20599753.

evaluatepharma.com (Global: low place; Catalan: low place)

nasdaqomxbaltic.com (Global: low place; Catalan: low place)

nih.gov (Global: 5th place; Catalan: 7th place)

ncbi.nlm.nih.gov

  • Sesti C, Simkhovich BZ, Kalvinsh I, Kloner RA «Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics». J. Cardiovasc. Pharmacol., 47, 3, 3-2006, p. 493–9. DOI: 10.1097/01.fjc.0000211732.76668.d2. PMID: 16633095.
  • Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M «Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction». J. Cardiovasc. Pharmacol., 48, 6, 12-2006, p. 314–9. DOI: 10.1097/01.fjc.0000250077.07702.23. PMID: 17204911.
  • Hayashi Y, Kirimoto T, Asaka N, Nakano M, Tajima K, Miyake H, Matsuura N «Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction». Eur. J. Pharmacol., 395, 3, 5-2000, p. 217–24. DOI: 10.1016/S0014-2999(00)00098-4. PMID: 10812052.
  • Leung IK, Krojer TJ, Kochan GT, Henry L, von Delft F, Claridge TD, Oppermann U, McDonough MA, Schofield CJ «Structural and mechanistic studies on γ-butyrobetaine hydroxylase». Chem. Biol., 17, 12, 12-2010, p. 1316–24. DOI: 10.1016/j.chembiol.2010.09.016. PMID: 21168767.
  • Tars K, Rumnieks J, Zeltins A, Kazaks A, Kotelovica S, Leonciks A, Sharipo J, Viksna A, Kuka J, Liepinsh E, Dambrova M «Crystal structure of human gamma-butyrobetaine hydroxylase». Biochem. Biophys. Res. Commun., 398, 4, 8-2010, p. 634–9. DOI: 10.1016/j.bbrc.2010.06.121. PMID: 20599753.

web.archive.org (Global: 1st place; Catalan: 1st place)